Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases
Authors:
- Timothy J. MilesTMTimothy J. Miles
- Christopher BarfootCBChristopher Barfoot
- Gerald BrooksGBGerald Brooks
- Pamela BrownPBPamela Brown
- Dongzhao ChenDCDongzhao Chen
- Steven DabbsSDSteven Dabbs
- David T. DaviesDDDavid T. Davies
- David L. DownieDDDavid L. Downie
- Susanne EyrischSESusanne Eyrisch
- Ilaria GiordanoIGIlaria Giordano
- Michael N. GwynnMGMichael N. Gwynn
- Alan HennessyAHAlan Hennessy
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (24) , 7483-7488
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Exploring Left-Hand-Side substitutions in the benzoxazinone series of 4-amino-piperidine bacterial type IIa topoisomerase inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- Type IIA topoisomerase inhibition by a new class of antibacterial agentsNature, 2010
- The clinical consequences of antimicrobial resistanceCurrent Opinion in Microbiology, 2009
- Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II TopoisomerasesAntimicrobial Agents and Chemotherapy, 2008
- Infectious Diseases: Safety Concerns with FluoroquinolonesAnnals of Pharmacotherapy, 2007
- Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: Synthesis and preliminary SAR analysisBioorganic & Medicinal Chemistry Letters, 2007
- Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strainsBioorganic & Medicinal Chemistry Letters, 2007
- Drugs for bad bugs: confronting the challenges of antibacterial discoveryNature Reviews Drug Discovery, 2006
- Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial AgentsChemical Reviews, 2005
- Antibiotics at the crossroadsNature, 2004